Reflections on the Merger of Molecular Endocrinology and Endocrinology

Total Page:16

File Type:pdf, Size:1020Kb

Reflections on the Merger of Molecular Endocrinology and Endocrinology EDITORIAL Reflections on the Merger of Molecular Endocrinology and Endocrinology ard though it is to imagine now-common- of interest to a particular group of researchers Hplace things as not existing, try to envis- could be published would be important. age the world of endocrinology when hor- Within The Endocrine Society, there were 2 mone receptors were just being discovered, schools of thought about how to do this: one be- Downloaded from https://academic.oup.com/mend/article/30/10/1019/2556327 by guest on 30 September 2021 signaling pathways just beginning to be re- lieved that it would be sufficient to dedicate a sec- vealed, and obtaining the gene that encoded a tion of our classic, flagship journal, Endocrinol- hormone was a finding worthy of publication ogy, to the new approach; the other felt that in Science. Such was the E. Brad Thompson, MD creating a new journal was state of endocrine science important, to clearly differ- when the idea of starting a Imitation is a high form of flattery, entiate what was a signifi- new Endocrine Society jour- and Molecular Endocrinology’s cant new scientific direction nal specifically devoted to format and policies were copied in for endocrine research. Fis- covering these areas was sug- start-ups by several other society cal considerations also had gested. A growing number of and free-standing journals. to be taken into account. endocrinology researchers Starting a journal would were frustrated by having no quality journal in which to cost money, and the enterprise could not be expected to publish their findings, which were often obtained through become self-supporting for several years. Furthermore, the use of the new, powerful technologies generally re- would the new journal diminish the importance of Endocri- ferred to by the freshly coined term “molecular biology.” nology? Would the 2 journals have to compete for papers? One could publish in a variety of general journals, of Feelings ran high at times, on both sides. Eventually, a con- course, or in journals devoted to endocrinology, including sensus was reached: there would be a new journal. In Eu- our own Endocrinology. The problem with specialty en- rope, Molecular and Cellular Endocrinology had just begun docrine journals, however, was that they had for many publishing. It was important that The Endocrine Society, years been publishing work concerning the magnificent America’s leader in endocrine research and practice, have discoveries of hormones, their physiology and biochem- representation in this important new area. istry. Consequently, they were perceived as mostly dedi- Unaware of all the above intrasociety background, I cated to such content. Most importantly, remember that shared the general sense of confusion and frustration over there were no search engines or worldwide webs. To find where to publish my own research. I had first heard the articles relevant to one’s own work, it was necessary to phrase molecular biology in a lecture at the National In- imagine where they might be published, find that journal stitutes of Health by Gordon Tomkins, who had just re- in a lab or library, and look for authors or relevant titles. turned from a sabbatical in France, where he had been Huge tomes of key word indices lay on library shelves, to exposed to many of the founders of the concept, scientists be looked through page by page. Then, if a likely article such as Jakob, Monod, and Changeux. Realizing that the was found, one hoped that that library had it on the field of endocrinology would be revolutionized by these shelves. If not, one sent off a letter to the authors or to the methods, I postponed, as it turned out, forever, my endo- National Library of Medicine requesting a paper copy, crine fellowship with Bob Williams in Seattle and joined which might arrive in a few weeks. In short, “keeping up Tomkins’ lab in 1964. Thus, I had been employing the with the literature” was difficult, frustrating, and uncer- new approaches for years when the question of a new tain. Having a single source in which important discoveries journal was being debated, and when it was suggested ISSN Print 0888-8809 ISSN Online 1944-9917 Printed in USA Copyright © 2016 by the Endocrine Society Received September 9, 2016. Accepted September 9, 2016. doi: 10.1210/me.2016-1128 Mol Endocrinol, October 2016, 30(10):1019–1020 press.endocrine.org/journal/mend 1019 1020 Thompson Mol Endocrinol, October 2016, 30(10):1019–1020 that I apply for the editorship of the new journal, I de- tiveness. Imitation is a high form of flattery, and Molec- cided to do so. As it turned out, I was selected. The drama ular Endocrinology’s format and policies were copied in surrounding that moment of selection has been recounted start-ups by several other society and free-standing jour- (Thompson, Molecular Endocrinology, the early years: nals. Unfortunately, our journal never achieved fiscal in- recollections by the first Editor-in-Chief. Mol Endocrinol. dependence and became accepted, more or less, as a “loss 1997;11(6):654–656). The consequence of being chosen leader” by the Society. Molecular biological methods are as the founding Editor-in-Chief was that I had to find an now employed in many endocrine researches and are seen answer to the question: How does one create a new, regularly in articles in the pages of Endocrinology. Above stand-out journal? all in importance has been the advent of the worldwide The Society gave me freedom to be creative. My Man- web and electronic publishing. Finding articles of interest, aging Editor, Pam Diamond, and I decided that form as no matter where published, now takes a matter of min- Downloaded from https://academic.oup.com/mend/article/30/10/1019/2556327 by guest on 30 September 2021 well as substance was important, so we created a cover utes, not days. Although the elitist views of some readers that differed from that of the other Society journals, chose still make publication in certain journals seem desirable, it a modern font and paper, selected what we hoped would is not so important that one or a few journals contain prove to be an attractive journal name, and, most impor- most of what one wants to read. One’s results, no matter tantly, adopted some editorial policies that were unusual where published, are available, in a very practical sense, at the time. to everyone. These circumstances have led the Society to Excepting a few, mostly weekly, journals, the publica- return to the original alternative of combining Endocri- tion process usually proceeded at a leisurely academic nology and Molecular Endocrinology, but in a new for- pace in those days. There was no prereview. One could mat, one which it is hoped will best satisfy the needs of expect the scientific review to consume 1–3 months. After endocrine researchers. Although I regret the loss of acceptance, publication could take more months. Instead, Molecular Endocrinology as an independent journal, we offered editorial prereview, allowing authors to send times change, and I earnestly wish high success to the in an abstract or short precursor version of their paper, to editors of our Society’s new, combined journal. see whether it seemed appropriate for the journal. We Dr. Thompson’s professional positions are Senior pledged a review turnaround time of 2 weeks and pursued Research Professor, Center for Nuclear Receptors and reviewers to meet that schedule. And we nagged the pub- Cell Signaling, University of Houston, TX and Professor lishers to get their job done in weeks, not months. We Emeritus, Department of Biochemistry and Molecular Bi- recruited an excellent panel of Associate Editors and Ed- ology, University of Texas Medical Branch, Galveston itors, easily recognizable as leaders in the field. Most im- Texas. portantly, we let our fellow scientists, inside and outside The Endocrine Society, know that we were looking for their best, most exciting results. Acknowledgments These tactics worked. The journal became the place to Address all correspondence and requests for reprints to: publish, and it achieved creditably high ratings as assessed Endocrine Society, 2055 L Street NW, Suite 600, Washington, by the various metrics that try to evaluate journal effec- DC 20036. E-mail: [email protected]..
Recommended publications
  • Transcription Factors Underlying the Development and Endocrine Functions of the Placenta † † † JAMES C
    Transcription Factors Underlying the Development and Endocrine Functions of the Placenta † † † JAMES C. CROSS,* LYNN ANSON-CARTWRIGHT, AND IAN C. SCOTT *Department of Biochemistry & Molecular Biology, University of Calgary Faculty of Medicine, Calgary, Alberta T2N 4N1 Canada; †Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5 Canada ABSTRACT The placenta has been the subject of extensive basic research efforts in two distinct fields. The developmental biology of placenta has been studied because it is the first organ to develop during embryogenesis and because a number of different gene mutations in mice result in embryonic lethality due to placental defects. The trophoblast cell lineage is relatively simple such that only two major, terminally differentiated cell types appear: an “invasive trophoblast” cell subtype such as extravillous cytotrophoblast cells in humans and trophoblast giant cells in mice, and a “transport trophoblast” cell subtype that is a syncytium (syncytiotrophoblast) in humans and mice. These two cell types also have been the focus of endocrinologists because they are the source of major placental hormones. Understanding the transcriptional regulation of placental hormone genes has given insights into the control of specificity of gene expression. Because most placental hormones are produced by very specific trophoblast cell subtypes, the transcriptional details promise to give insights into cell-subtype specification. The fields of developmental biology and molecular endocrinology appear to be meeting on this common ground with the recent discovery of key transcription factors. Specifically, the basic helix-loop-helix (bHLH) transcription factor Hand1 is essential for differen- tiation of trophoblast giant cells in mice and also regulates the promoter for the giant cell-specific hormone, placental lactogen I gene (Pl1).
    [Show full text]
  • What You Can Expect at This Year's All-Virtual ENDO
    TUNE INTO ENDO2021 — MARCH 20–23, 2021 MARCH 2021 THE LEADING MAGAZINE FOR ENDOCRINOLOGISTS ● On the Right Track: How the many paths of G Protein-Coupled Receptors could lead to treatment breakthroughs in the future ● Opening Arguments: Both sides make their points about using radioactive iodine treatment for PREVIEW hyperthyroidism and its associated What You Can Expect at cancer risks ● No Place Like Home: How This Year’s All-Virtual ENDO environmental factors impact disparities in obesity treatment As this year’s annual conference transitions to online-only for the first time, the world’s leading experts in endocrine science and ● Lifetime Care: A comprehensive treatment converge to share the latest scientific discoveries and look at treating transgender patients cutting-edge breakthroughs in patient care. throughout their lives A CHEMIST AT HEART: In the lab with Richard J. Auchus, MD, PhD CRITICAL CARE: How COVID-19 impacted CGM use in hospitals NOW AVAILABLE TEST YOUR KNOWLEDGE WITH THE #1 SELF-ASSESSMENT TOOL IN THE FIELD • 120 brand-new case questions • Interactive online module with three learning modes • NEW! FLEXIBLE FORMAT OPTION: Select from a printed book or e-Book to complement the online module • Lab values in conventional and SI Units • 40.0 AMA PRA Category 1 Credits™ and ABIM MOC Points ORDER ONLINE AT ENDOCRINE.ORG/STORE © 2021 ENDOCRINE SOCIETY ESAP_2021_AD.indd 1 2/2/21 2:50 PM CLINICAL PRACTICE GUIDELINES FROM THE ENDOCRINE SOCIETY THE LEADING MAGAZINE FOR ENDOCRINOLOGISTS 2020 – 2022 EDITORIAL ADVISORY BOARD Henry Anhalt, DO Bergen County Pediatric Endocrinology Sally Camper, PhD Department of Human Genetics University of Michigan Medical School Rodolfo J.
    [Show full text]
  • Endocrine-Disrupting Chemicals and Cardiovascular Health
    HIGHLIGHTS FROM AUGUST 2020 THE LEADING MAGAZINE FOR ENDOCRINOLOGISTS INTERNATIONAL IN A heartbeat Endocrine-Disrupting Chemicals and Cardiovascular Health As heart disease continues to kill more Americans than any other ailment each year, more endocrine research is linking endocrine disruptors to cardiovascular health. Despite a lack of significant action to reduce EDCs, patients can take steps to avoid exposure to these compounds. CEU 2020 PREVIEW: An investigation into “thyroid imposters” SPECIAL INTEREST GROUPS: Introducing the Endocrine Society’s Transgender SIG THE LEADING MAGAZINE FOR ENDOCRINOLOGISTS 2020 – 2022 EDITORIAL ADVISORY BOARD Henry Anhalt, DO Bergen County Pediatric Endocrinology Sally Camper, PhD Department of Human Genetics University of Michigan Medical School Rodolfo J. Galindo, MD Assistant Professor of Medicine Mount Sinai School of Medicine Christian M. Girgis, MBBS, PhD, FRACP Royal North Shore and Westmead Hospitals University of Sydney, Australia Andrea Gore, PhD Division of Pharmacology and Toxicology University of Texas Daniel A. Gorelick, PhD Baylor University, Houston, Texas M. Carol Greenlee, MD, FACP Western Slope Endocrinology Grand Junction, Colo. (Faculty for Transforming Clinical Practice initiative [TCPi]) Gary D. Hammer, MD, PhD Millie Schembechler Professor of Adrenal Cancer, Endocrine Oncology Program University of Michigan Robert W. Lash, MD Chief Professional & Clinical Officer, Endocrine Society Karl Nadolsky, DO Assistant Clinical Professor of Medicine, MSU College of Human Medicine SHMG Endocrinology Joshua D. Safer, MD, FACP Executive Director, Center for Transgender Medicine and Surgery Mount Sinai Health System Professor of Medicine Icahn School of Medicine at Mount Sinai TUNE INTO OUR New York, NY Shehzad Topiwala, MD, FACE NEW JOURNAL CLUB Endocrinology Department SevenHills Hospital, Mumbai, India PODCAST SERIES Kristen R.
    [Show full text]
  • Association of American Medical Colleges
    association of american medical colleges MEETING SCHEDULE COUNCIL OF ACADEMIC SOCIETIES ADMINISTRATIVE BOARD January 19, 1983 5:30 p.m. Joint CAS/COD Administrative Boards p Meeting (see pg. 9) Hemisphere Room without 7:00 p.m. Joint Reception and Dinner Thoroughbred Room reproduced be to January 20, 1983 Not 9:00 a.m. CAS Administrative Board Meeting Edison Room AAMC the 1:00 p.m. Joint Administrative Boards Luncheon Map Room of 2:00 p.m. Adjournment collections the one dupont circle, n.w./washington, d.c. 20036 S AGENDA COUNCIL OF ACADEMIC SOCIETIES ADMINISTRATIVE BOARD I. Report of the Chairman ACTION ITEMS A. Approval of the Minutes of September 8-9 1 CAS Administrative Board permission B. Appointment of 1983 CAS Nominating Committee 6 C. Executive Council Action Items with Particular Emphasis On: without C. Report of the AAMC Officers' Retreat 25 D. Undergraduate Medical Education Preparation for reproduced Improved Geriatric Care--A Guideline for Curriculum be Assessment 35 to Payment Proposals for Hospital Services Not F. Prospective Provided to Medicare Beneficiaries 68 AAMC H. The Future of the AAMC's Management Education Programs 91 the of I. ACCME Essentials and Guidelines 93 J. ACCME Protocol for Recognizing State Medical Societies as Accreditors of Local CME 110 collections the DISCUSSION ITEMS from A. A Proposed Sliding Scale of Grant Awards for Biomedical Research 9 B. AAMC Awards 14 Document C. CAS Interim Meeting Plans 15 • S MINUTES COUNCIL OF ACADEMIC SOCIETIES ADMINISTRATIVE BOARD September 8-9, 1982 Washington Hilton Hotel Washington, DC PRESENT: Board Members AAMC Staff David M.
    [Show full text]
  • Obesity Prevalence Sex Differences in Adults Aged 20+ Years
    OBESITY PREVALENCE SEX DIFFERENCES IN ADULTS AGED 20+ YEARS 35.1% ADULTS Overall US 33.5% vs. 36.1% 46.44% vs. 65.38% Prevalence of Obesity1 16.9% Obesity Metabolic Syndrome 2 CHILDREN BMI ≥ 30 kg/m with abdominal obesity Overall US Prevalence of Obesity1 COST BURDEN 22.9% PER ADULT WITH OBESITY ANNUAL MEDICAL SPENDING PER CAPITA4 ADULTS $3,976 Overall US Prevalence of Metabolic 5 Syndrome2 MEAN 10-YEAR TOTAL MEDICAL COSTS FOR US ADULTS $40,873 vs. $33,010 4.5% WITH METABOLIC NO METABOLIC SYNDROME SYNDROME CHILDREN Overall US 1 Source: NHANES 2011-2012 Prevalence of Metabolic 2 Source: NHANES 2009-2010 Syndrome3 3 Source: NHANES 1999-2004 4 Source: Medical Expenditure Panel Survey, 2001 5 Source: Curtis et al., 2007 © 2015 The Endocrine Society. All rights reserved. Endocrine Society 2055 L Street NW, Suite 600 Washington, DC 20036 USA Phone: 202.971.3636 Fax: 202.736.9705 endocrine.org Mission Statement of the Acknowledgements For More Information Endocrine Society The production of Endocrine Facts For more information, updates, and The mission of the Endocrine and Figures would not have been the online version of this report, visit: Society is to advance excellence possible without the guidance of: endocrinefacts.org in endocrinology and promote its essential and integrative role Advisory Panel Suggested Citation in scientific discovery, medical Robert A. Vigersky, MD (Chair) The Endocrine Society requests that practice, and human health. Walter Reed National Military this document be cited as follows: Medical Center The Endocrine Society. Endocrine About Endocrine Facts Facts and Figures: Obesity. First and Figures Ursula B.
    [Show full text]
  • INTRODUCTION to ENDOCRINE DISRUPTING CHEMICALS (Edcs) a GUIDE for PUBLIC INTEREST ORGANIZATIONS and POLICY-MAKERS
    INTRODUCTION TO ENDOCRINE DISRUPTING CHEMICALS (EDCs) A GUIDE FOR PUBLIC INTEREST ORGANIZATIONS AND POLICY-MAKERS Andrea C. Gore, PhD David Crews, PhD Loretta L. Doan, PhD Michele La Merrill, PhD, MPH Heather Patisaul, PhD Ami Zota, ScD, MS December 2014 A JOINT ENDOCRINE SOCIETY–IPEN INITIATIVE TO RAISE GLOBAL AWARENESS ABOUT ENDOCRINE-DISRUPTING CHEMICALS Founded in 1916, the Endocrine Society is the world’s oldest, largest, and most active organization devoted to research on hor- mones and the clinical practice of endo- crinology. The Endocrine Society’s mem- bership consists of over 18,000 scientists, physicians, educators, nurses, and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. Included among the Society’s members are the world’s leading experts on the health effects of EDCs. Endocrine Society members have been at the forefront of scientific advancements in the field of EDCs since it was first recognized that exogenous chemicals can have effects on endocrine systems. The Society held its first public meeting on EDCs in conjunction with its Annual Meeting in San Francisco in 2005. The So- ciety’s landmark 2009 Scientific Statement on EDCs was the first comprehensive review of the EDC literature, and it represented the first public statement on the issue from a major mainstream international medical society. IPEN is a leading global network of 700 non-governmental organizations (NGOs) working in more than 100 developing countries and countries with economies in transition. IPEN works to establish and implement safe chemicals policies and practices to protect human health and the environment.
    [Show full text]
  • ENDOCRINOLOGY EDITOR-IN-CHIEF CAROL LANGE, Phd
    Q&A: NEW ENDOCRINOLOGY EDITOR-IN-CHIEF CAROL LANGE, PhD JULY 2020 THE LEADING MAGAZINE FOR ENDOCRINOLOGISTS INTERNATIONAL Virtual ENDOCRINOLOGY The Rise of Telehealth During COVID-19 Social distancing has dramatically impacted how physicians can treat — or even see — their patients. Thankfully, technology has come to the rescue. Endocrine News explores how telemedicine has safely brought doctors and patients face to face during this pandemic and how it may have changed the future of healthcare forever. DRONING ON: Insulin delivery from above! TWEETING DURING COVID-19: Using social media while social distancing. THE LEADING MAGAZINE FOR ENDOCRINOLOGISTS 2020 – 2022 EDITORIAL ADVISORY BOARD Henry Anhalt, DO Bergen County Pediatric Endocrinology Sally Camper, PhD Department of Human Genetics University of Michigan Medical School Rodolfo J. Galindo, MD Assistant Professor of Medicine Mount Sinai School of Medicine Christian M. Girgis, MBBS, PhD, FRACP Royal North Shore and Westmead Hospitals University of Sydney, Australia Andrea Gore, PhD Division of Pharmacology and Toxicology University of Texas Daniel A. Gorelick, PhD Baylor University, Houston, Texas M. Carol Greenlee, MD, FACP Western Slope Endocrinology Grand Junction, Colo. (Faculty for Transforming Clinical Practice initiative [TCPi]) HEAR FROM LEADERS Gary D. Hammer, MD, PhD Millie Schembechler Professor of Adrenal Cancer, IN ENDOCRINOLOGY Endocrine Oncology Program University of Michigan Robert W. Lash, MD Discover insights from the experts Chief Professional & Clinical Officer, Endocrine Society on how to provide care to patients Karl Nadolsky, DO Assistant Clinical Professor of Medicine, with a variety of common and rare MSU College of Human Medicine SHMG Endocrinology conditions. Earn 30 AMA PRA Joshua D.
    [Show full text]
  • Managingsex LUPUS
    ® DECEMBER 2012 news ManagingSex LUPUS PLUS Counterfeit Drugs Detecting Sjögren’s and Klinefelter Zoo Endocrinology 01_Cover_Dec2012.indd 1 11/19/12 1:22 PM KRdbts.fpENDO1211_x1a.pdf 1 10/14/12 5:17 PM 02-03 TOC DEC2012.indd 2 11/19/12 1:23 PM KRdbts.fpENDO1211_x1a.pdf 1 10/14/12 5:17 PM DECEMBER 2012 Vol. 37 No. 12 contents NEWS & INSIGHTS FOR THE ENDOCRINE COMMUNITY WWW.ENDO-SOCIETY.ORG Features Departments COVER STORY Systemic Lupus and Hormones 4 ...............................................Viewpoint 16 By Drs. Ida Dzifa Dey, David A. Isenberg, 5 .........................................Editor’s Page Robert G. Lahita, and Cherie Butts Four specialists discuss the impact of endocrine systems on this multifac- 12 ..............................Trends & Insights eted and debilitating autoimmune disease. 28 ...................................Trainee Corner Puzzling Conditions 35 .................................Research Briefs 24By Terri D’Arrigo and Glenda Fauntleroy pg. 16 .............................................Spotlight Like Lupus, the complex symp- 41 toms of Sjögren’s and Klinefelter syndromes make them difficult to 46 ..................................Society Update detect. 49 .................................................Donors Counterfeit Drugs 54 ..........................................Back Story 36By Shannon Fischer When the commercial use of the Internet went global, it opened the 59 .........................................Classifieds floodgates for fake pharmaceuticals. Zoo Fertility Specialist 54By Dan Kelly For Smithsonian Institution’s animal reproductive scientist Janine Brown, pg. 36 endocrinology is critical in the ef- forts to preserve endangered species. DECEMBER 2012 Scan this QR code with your smartphone/mobile NEWS • pg. 54 device for Endocrine News Online. ENDOCRINE 3 02-03 TOC DEC2012.indd 3 11/19/12 1:23 PM VIEWPOINT Those who receive the Early Career Forum Travel Award are also provided with complimentary registration to attend ENDO 2013.
    [Show full text]
  • Exercise/Adenosine Stress Test Report
    The Endocrine Society Oral History Collection The Clark Sawin Library DANIEL D. FEDERMAN, MD Interview conducted by Michael Chappelle June 19, 2010 Copyright © 2010 by The Endocrine Society ii All uses of this manuscript are covered by a legal agreement between The Trustees of The Endocrine Society and Daniel Federman, dated June 19, 2010. The manuscript is thereby made available for research purposes. All literary rights in the manuscript, including the right to publish, are reserved to The Clark Sawin Library. No part of the manuscript may be quoted for publication without the written permission of the Director of Clark Sawin Library. Requests for permission to quote for publication should be addressed to The Endocrine Society Office, The Clark Sawin Library, Chevy Chase, Maryland, 20815, and should include identification of the specific passages to be quoted, anticipated use of the passages, and identification of the user. It is recommended that this oral history be cited as follows: Daniel D. Federman, MD, an oral history conducted in 2010 by Michael Chappelle, The Endocrine Society, The Clark Sawin Library, Chevy Chase, Maryland, 2010. iii INTRODUCTION Daniel D. Federman, MD, Carl W. Walter Distinguished Professor of Medicine at Harvard Medical School (HMS) is a nationally respected and influential medical educator and academic leader. His exceptional skills as a communicator have proven invaluable to promoting high standards of medical education and ethical practice as well as implementing innovative changes in the medical curriculum. Dr. Federman has also been a leader in postgraduate education for physicians, contributing effectively to the educational programs of the American College of Physicians, of which he was president in 1982.
    [Show full text]
  • Program Guide June 8–22, 2020 Endoonline.Endocrine.Org
    PROGRAM GUIDE JUNE 8–22, 2020 ENDOONLINE.ENDOCRINE.ORG LAST UPDATED JUNE 5, 2020 THANK YOU TO OUR SUPPORTERS THE ENDOCRINE SOCIETY IS PROUD TO PARTNER WITH PEERS AND INDUSTRY TO ADVANCE EXCELLENCE AND PROMOTE SCIENTIFIC DISCOVERY, MEDICAL PRACTICE, AND HUMAN HEALTH. ENDO ONLINE 2020 SUPPORTERS AS OF JUNE 1, 2020. ENDOCRINE SOCIETY | ENDO ONLINE 2020 PROGRAM GUIDE | FOR MORE INFORMATION, VISIT ENDOONLINE.ENDOCRINE.ORG II THANK YOU TO OUR PARTNER SOCIETIES WHO HAVE OFFERED THEIR ENDORSEMENT AND HELPED TO PROMOTE THIS OPPORTUNITY TO THE ENDOCRINE COMMUNITY. ENDO ONLINE 2020 PARTNER SOCIETIES AS OF MAY 20, 2020. ENDOCRINE SOCIETY | ENDO ONLINE 2020 PROGRAM GUIDE | FOR MORE INFORMATION, VISIT ENDOONLINE.ENDOCRINE.ORG III TABLE OF CONTENTS 2 GENERAL INFORMATION 4 LIVE AND ANCILLARY SYMPOSIA SESSIONS: JUNE 8–12 9 BASIC SCIENCE DAY: JUNE 8 13 LIVE AND ANCILLARY SYMPOSIA SESSIONS: JUNE 15–19 15 ON-DEMAND SESSIONS 19 25TH ANNIVERSARY OF DIVERSITY AND INCLUSION 20 AWARD AND LAUREATE RECIPIENTS 21 PRODUCT THEATERS AND EXHIBIT HALL VIEWING ENDOCRINE SOCIETY | ENDO ONLINE 2020 PROGRAM GUIDE | FOR MORE INFORMATION, VISIT ENDOONLINE.ENDOCRINE.ORG 1 GENERAL INFORMATION We are excited to offer ENDO Online 2020, our largest-ever virtual meeting ENDO 2021 for endocrine researchers and clinicians. This complimentary event will take ENDO is the place where leading experts, place June 8-22, and will feature a comprehensive mixture of on-demand and researchers, and the most respected live programming, offering attendees the opportunity to learn about the latest clinicians in the field come together to developments in hormone science and medicine from renowned investigators, share the latest findings in hormone expert clinicians, and educators from all over the world.
    [Show full text]
  • Challenges and Opportunities in Genetic Counseling for Hereditary Endocrine Neoplasia Syndromes
    27 8 Endocrine-Related P Brock, J L Geurts et al. Genetic counseling and 27:8 T65–T75 Cancer endocrine neoplasias THEMATIC REVIEW HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES Challenges and opportunities in genetic counseling for hereditary endocrine neoplasia syndromes Pamela Brock1,*, Jennifer L Geurts2,*, Paulien Van Galen3, Erica Blouch4, James Welch5, Amy Kunz6, Lauren Desrosiers7, Jennifer Gauerke8 and Samuel Hyde9 1Divison of Human Genetics, Department of Internal Medicine and the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA 2Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA 3Hereditary Cancer Clinic and Hereditary Endocrine Clinic, Alberta Children’s Hospital, Calgary, Alberta, USA 4Center for Cancer Risk Assessment, Massachusetts General Hospital, Boston, Massachusetts, USA 5Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland, USA 6Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania, USA 7Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas, USA 8Center for Individualized Medicine, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA 9Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Correspondence should be addressed to S Hyde: [email protected] *(P Brock and J L Geurts contributed equally to this work) This paper is part of a thematic section on current
    [Show full text]
  • COVID-19'S Impact on Patients with Common Comorbidities
    RESEARCHERS ROUNDTABLE: THE 2021 EARLY INVESTIGATOR AWARD WINNERS JUNE 2021 THE LEADING MAGAZINE FOR ENDOCRINOLOGISTS INTERNATIONAL REVIEW COVID-19’s Collision Impact on Patients with Common COURSE Comorbidities ● Obesity is associated with more severe COVID-19 effects and ICU stays but not with increased mortality. ● Hyperglycemia is linked to a higher risk of death in COVID-19 patients both with and without diabetes. ● Children with adrenal insufficiency and COVID-19 have a significantly higher risk of complications, mortality rate, endotracheal intubation, and sepsis. ● Patients with low vitamin D levels were less likely to be ventilated or to die from COVID-19. PEER REVIEW: A professional partnership examines CVD and diabetes TOUTING TEAMWORK: Inpatient Diabetes Management Service’s impact in community hospitals ACCEPTING NOMINATIONS FOR OUR 2022 BOARD OF DIRECTORS We are accepting seeking dedicated member leaders to serve on our Board of Directors for the 2022-2023 term. Nominate yourself or a colleague for one of the following positions: • President-Elect • At-Large Directors (4 open positions) LEARN MORE AND SUBMIT A NOMINATION TODAY: ENDOCRINE.ORG/2022DIRECTORS DEADLINE: 11:59 PM EDT ON JUNE 30 © 2021 ENDOCRINE SOCIETY Board_Directors_EndocrineNews_June.indd 1 4/30/21 1:53 PM SAD THAT YOU MISSED ENDO 2021? THE LEADING MAGAZINE FOR ENDOCRINOLOGISTS 2020 – 2022 EDITORIAL ADVISORY BOARD Henry Anhalt, DO Bergen County Pediatric Endocrinology Sally Camper, PhD Department of Human Genetics University of Michigan Medical School Rodolfo J. Galindo, MD Assistant Professor of Medicine Mount Sinai School of Medicine Christian M. Girgis, MBBS, PhD, FRACP Royal North Shore and Westmead Hospitals University of Sydney, Australia Andrea Gore, PhD Division of Pharmacology and Toxicology University of Texas Daniel A.
    [Show full text]